| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > How To Conduct A Successful S.W.O.T. Analysis |
|
Advice You - How To Conduct A Successful S.W.O.T. Analysis
SWOT Analysis: When you and your group wish to identify your Strengths and Weaknesses, the Opportunities available and the Threats facing you. This is a powerful and highly successful technique that can be applied to an individual, a group, a team, a company, a plan – think about it, even a website! Again, experiment with i According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product t. If it helps you to focus your (and your team’s) efforts in the right direction, it’s worth it. The process is to ask and answer a number of specific questions for each of the 4 categories, documenting the answers. This process, in itself is simple enough. However, so that you are not disappointed with the outcome, take the time ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in you need, get the answers you need, face the facts and above all, take action. TIP Whether working on this for yourself or with your team, always keep in mind the goal you want to achieve for each category. So, in this context, treat 'you' as either yourself, your team, your improvement group, your company, yo lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ur business. The starting point of a successful SWOT analysis is to understand that there are 4 general objectives, one for each part of the analysis, the goal you wish to achieve. Typical Format - the most common approach and widely used format is to construct a 2 row by 2 column matrix with the following information... STRENG here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe HS in top left quadrant Capitalise on your strengths WEAKNESSES in top right quadrant Address your weaknesses OPPORTUNITIES in bottom left quadrant Take full advantage of the opportunities available THREATS in bottom right quadr d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro nt Deal with or minimise the impact of threats you face Although each of the above statements can be regarded as action oriented, they are, in themselves, meaningless. We can't use them to communicate exactly what our plans are going to be, why we have the plans in the first place, what resources we need ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc and who will implement the plans. So, let's ask a few fundamental questions to put some meat on the skeleton... ---Sidebar--- Add to or tailor the questions to suit you, your team, your organization. ---End Sidebar--- STRENGTHS easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi service areas do you excel?
Answer from your own point of view, your customers’ your teams', your suppliers' and others. WEAKNESSES nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically >What do you not do well? How do you know?
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ Are decisions based on supposition or hard data?
Answer from your own point of view, your customers’ and others. Face the Truth OPPORTUNITIES ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ties would help you become more successful?
technology, demographics, legislation, education Use PDCA (see footnotes) to identify those that will give you the greatest return ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a HREATS dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod e dealt with or overcome?
Use PDCA (see footnotes) to prioritize O.K., we have done the data gathering, the surveys, the questioning, the 'soul searching'. Redraw the matrix when questioning round is complete replacing the questions asked in each quadrant with a summary of the answers. Easy for cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e to say I know but... As long as you have been factual As long as you have been honest especially with yourself As long as you are ready and prepared to accept the answers As long as you are prepared to TAKE ACTION You have the foundation here to take a snapshot of where you are today, what's working tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen or and against you, and the basis for a series of action plans to get you to where you want to be tomorrow. Regardless of which quadrant you may be studying, the key question to ask yourself is... "What will give us the biggest return" Many of us are familiar with the "Pareto Principle", perhaps t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel more familiar with the term "80-20 Rule" Pareto Principle Why the 80-20 rule? Approximately 80% of trouble comes from 20% of the problems. Also, quite often, 80% of the results we seek, will come from 20% of our efforts - as long as we are focused and prioritize. Although "Pareto" is name ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust after the economist Vilfredo Pareto, it was Dr. Joseph M. Duran who applied the thinking to management best practices. Dr. Juran advises us to concentrate on the "vital few" sources of problems (and in this context, the actions which will give us the greatest return) and not be distracted by those of lesser y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products mpact or importance. To conclude, be as creative as you can be in your problem solving, think 'outside the box'. Get others to do the same. As much as I hate them, just think of "yellow stickies" and how a complete disaster became a huge income generator. If you are worried about change just imagine what will h . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de appen if you do nothing! "Insanity: doing the same thing over and over again and expecting different results." Einstein Footnotes elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Analyis, Cause and Effect Diagrams (Fishbone Diagrams),Flowcharting. =============================================================== tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Creating a Goals Centred Management System
|